JP2013540714A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540714A5
JP2013540714A5 JP2013526503A JP2013526503A JP2013540714A5 JP 2013540714 A5 JP2013540714 A5 JP 2013540714A5 JP 2013526503 A JP2013526503 A JP 2013526503A JP 2013526503 A JP2013526503 A JP 2013526503A JP 2013540714 A5 JP2013540714 A5 JP 2013540714A5
Authority
JP
Japan
Prior art keywords
alkyl
group
heterocyclyl
carbocyclyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013526503A
Other languages
English (en)
Japanese (ja)
Other versions
JP5928737B2 (ja
JP2013540714A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/065332 external-priority patent/WO2012032014A1/en
Publication of JP2013540714A publication Critical patent/JP2013540714A/ja
Publication of JP2013540714A5 publication Critical patent/JP2013540714A5/ja
Application granted granted Critical
Publication of JP5928737B2 publication Critical patent/JP5928737B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013526503A 2010-09-06 2011-09-05 エチン誘導体、医薬組成物及びその使用 Expired - Fee Related JP5928737B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10175456 2010-09-06
EP10175456.2 2010-09-06
PCT/EP2011/065332 WO2012032014A1 (en) 2010-09-06 2011-09-05 Ethyne derivatives, pharmaceutical compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2013540714A JP2013540714A (ja) 2013-11-07
JP2013540714A5 true JP2013540714A5 (enExample) 2014-10-23
JP5928737B2 JP5928737B2 (ja) 2016-06-01

Family

ID=44584179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013526503A Expired - Fee Related JP5928737B2 (ja) 2010-09-06 2011-09-05 エチン誘導体、医薬組成物及びその使用

Country Status (4)

Country Link
US (1) US8877754B2 (enExample)
EP (1) EP2614054B1 (enExample)
JP (1) JP5928737B2 (enExample)
WO (1) WO2012032014A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014184104A1 (en) * 2013-05-17 2014-11-20 Boehringer Ingelheim International Gmbh Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
MX2016002479A (es) 2013-09-12 2016-05-31 Pfizer Uso de inhibidores de acetil-coa carboxilasa para tratar acne vulgaris.
EP2924027A1 (en) * 2014-03-28 2015-09-30 Basf Se Substituted [1,2,4]triazole and imidazole fungicidal compounds
HUE047225T2 (hu) 2014-12-16 2020-04-28 Novartis Ag LpxC inhibitor izoxazol hidroxámsav-vegyületek
WO2017117708A1 (en) * 2016-01-05 2017-07-13 Hua Medicine (Shanghai) Ltd. Pyrazole derivatives
SMT202000524T1 (it) 2016-06-14 2020-11-10 Novartis Ag Forma cristallina di (r)-4-(5-(ciclopropiletinil)isossazol-3-il)-n-idrossi-2-metil-2-(metilsolfonil)butanammide come agente antibatterico
CN119954697A (zh) * 2018-08-24 2025-05-09 赛尼欧普罗有限责任公司 用于治疗病态状况的芳香型分子

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042584A (en) * 1974-08-19 1977-08-16 Merck & Co., Inc. Ethynylaryl phenyl cyclopropyl thiazines and morpholines
JP3894949B2 (ja) * 1993-06-30 2007-03-22 ザ、ウェルカム、ファンデーション、リミテッド 抗アテローム性動脈硬化症ジアリール化合物
EP1282612B1 (en) * 2000-05-03 2004-12-29 F. Hoffmann-La Roche Ag Alkynyl phenyl heteroaromatic glucokinase activators
KR20030030029A (ko) * 2000-09-22 2003-04-16 니혼노야쿠가부시키가이샤 Ｎ-(4-피라졸릴)아미드 유도체 및 농원예용 약제 그리고그 사용방법
DE10219294A1 (de) * 2002-04-25 2003-11-13 Schering Ag Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
US7524862B2 (en) 2004-04-14 2009-04-28 Boehringer Ingelheim International Gmbh Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
EP2069313A2 (en) 2006-06-29 2009-06-17 Alantos Pharmaceuticals Holdings, Inc. Metalloprotease inhibitors
AU2009206775A1 (en) 2008-01-22 2009-07-30 Merck Patent Gmbh Protein kinase inhibitors and use thereof
JP5535931B2 (ja) 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物

Similar Documents

Publication Publication Date Title
JP2013541513A5 (enExample)
JP2024521979A5 (enExample)
JP2015506355A5 (enExample)
CN109963854A (zh) 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
JP2013512903A5 (enExample)
JP2018502101A5 (enExample)
RU2012104700A (ru) Азабициклосоединение и его соль
RU2018111439A (ru) Новое пиразоло[3, 4-d]пиримидиновое соединение или его соль
RU2012127792A (ru) Пиразолопиримидины и родственные гетероциклы как ск2 ингибиторы
FI3518960T3 (fi) Annostusohjelma kontrolloidusti vapautuvalle PTH-yhdisteelle
JP2015503540A5 (enExample)
JP2007536241A (ja) 糖尿病性腎症の処置のためのａ２ａアデノシンレセプターアゴニスト
JP2015500856A5 (enExample)
JP2014509600A5 (enExample)
JP2013518036A5 (enExample)
JP2014516070A5 (enExample)
RU2015121044A (ru) Производные фенилэтилпиридина в качестве ингибиторов pde4
JP2015500267A5 (enExample)
CN115335047B (zh) 用于治疗血管脂肪瘤的组合物
JP2024504927A5 (enExample)
RU2020113456A (ru) Профилактическое и/или терапевтическое средство против заболеваний, связанных с экспрессией ido
RU2015155032A (ru) Тилозиновые производные и способ их получения
KR20130103650A (ko) (ｅ)-4-카복시스티릴-4-클로로벤질설폰의 개선된 안정한 수성 제형
JP2015504861A5 (enExample)
US20040209916A1 (en) Combination therapies